News | February 27, 2022
Daewoong completes combination therapy of antidiabetic drug Enavogliflozin
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
Confirmed positive phase 3 topline results in addition to Enavogliflozin monotherapy and Metformin combination therapy
Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy
Study to evaluate effectiveness of hypoglossal nerve stimulation
The joint initiative is called J-ARC Healthcare Solutions
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
New biotechnology product aims to be world's fastest automatic sanitary solution
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core(basis.
Daewoong delivered KRW 1.055 trillion in sales, KRW 95.5 billion in operating profit and KRW 40.5 billion in net profit.
Subscribe To Our Newsletter & Stay Updated
